From the Research
Intra-Articular Injection of BPC-157
- The provided studies do not directly address the gauge of needle used for intra-articular injection of BPC-157 into the shoulder joint.
- However, studies 1 and 2 discuss the distance to the subacromial bursa and glenohumeral joint, which may be relevant to determining the appropriate needle length and gauge for intra-articular injections in the shoulder joint.
- Study 1 suggests that a standard 22- or 25-gauge needle may be suitable for reaching the subacromial bursa from anterior and lateral approaches, but may not be sufficient for a posterior approach.
- Study 2 recommends using an injection needle of 2 inches or greater to reliably access the shoulder joint via the Neviaser approach, with the length potentially increasing with increasing body mass index (BMI).
- There is no direct information on the gauge of needle used for BPC-157 injections, but studies 3 and 4 discuss intra-articular injections in general, and study 5 discusses the use of BPC-157 for treating interstitial cystitis, which may not be directly relevant to shoulder joint injections.